BerandaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
$1,20
Rentang hari
$1,19 - $1,33
Rentang tahun
$1,13 - $5,00
Kapitalisasi pasar
48,48Â jt USD
Volume Rata-Rata
34,28Â rb
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 17,09Â jt | -31,88% |
Laba bersih | -16,93Â jt | 28,87% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,43 | 30,65% |
EBITDA | -16,93Â jt | 33,04% |
Tarif pajak efektif | 0,04% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 117,77Â jt | -31,93% |
Total aset | 186,75Â jt | -24,13% |
Total liabilitas | 29,96Â jt | 4,51% |
Total ekuitas | 156,79 jt | — |
Saham yang beredar | 39,41 jt | — |
Harga terhadap nilai buku | 0,30 | — |
Tingkat pengembalian aset | -22,78% | — |
Tingkat pengembalian modal | -24,84% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -16,93Â jt | 28,87% |
Kas dari operasi | -12,01Â jt | 29,20% |
Kas dari investasi | -192,00Â rb | 93,65% |
Kas dari pembiayaan | 358,00Â rb | 1.178,57% |
Perubahan kas bersih | -12,20Â jt | 33,34% |
Arus kas bebas | -6,73Â jt | 63,86% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
130
